Literature DB >> 4383855

The absorption and urinary excretion in man of fenfluramine and its main metabolite.

A H Beckett, L G Brookes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4383855

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  12 in total

1.  Treatment of obesity with fenfluramine.

Authors:  I Persson; U Andersen; T Deckert
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

2.  Evidence for an unusual distribution of chlorphentermine in vivo. An autoradiographic study in mice.

Authors:  K U Seiler; O Wassermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics.

Authors:  J R Dykes
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

4.  Kinetics of fenfluramine isomers in the rat.

Authors:  S Caccia; G Dagnino; S Garattini; G Guiso; R Madonna; M G Zanini
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

Review 5.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

6.  Preliminary assessment of flutiorex, a new anorectic drug, in man.

Authors:  J F Giudicelli; C Richer; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 7.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

8.  Pharmacokinetics of fenfluramine enantiomers in man.

Authors:  S Caccia; M Ballabio; P De Ponte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

9.  Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.

Authors:  S Caccia; I Conforti; J Duchier; S Garattini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
.

Authors:  Brooks Boyd; Steven Smith; Arnold Gammaitoni; Bradley S Galer; Gail M Farfel
Journal:  Int J Clin Pharmacol Ther       Date:  2019-01       Impact factor: 1.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.